Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...

Andrew Taylor announced on April 22 as new EVP Food & Beverages, joining the company no later than September 1, 2025. 2025 outlook maintained: 5-8% organic sales growth (6-9% excluding the exit from ...

Oslo, Norway, 8 May 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, announces its first ...

Martin Olin, Chief Executive Officer at Swarm Oncology will deliver the presentation on Novel Immunotherapy for Solid Cancers. Title: Novel Immunotherapy for Solid Cancers Presenter: Martin Olin ...

Leiden, the Netherlands, May 8, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary unaudited financial report for the three ...

The first quarter 2025 financial results and business update will be discussed during a conference call and webcast presentation today at 2:30 pm CET/8:30 am ET. A webcast of the live call may be ...

Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, strengthening of organizational capabilities, and strategic partnership for ...

Bioma achieves this by delivering good bacteria to the gut, hence balancing the microbiome. Nourishing prebiotics to ...

Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.

In light of the preliminary Q1 results and the integration of the Danish-based freight forwarder DTK, we are updating our full-year outlook for 2025 as follows: Adj. EBIT of DKK 560 - 630 million ...

About Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the ...

REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...